Grand Brilliance Group Holdings Limited provided consolidated earnings guidance for the year ended 31 March 2023. For the period, the company expects record a consolidated profit attributable to the owners of the Company of approximately HKD 7.2 million to HKD 7.8 million. It increased significantly when compared with the consolidated profit attributable to the owners of the Company of approximately HKD 4.0 million for the year ended 31 March 2022, primarily attributable to increase in revenue of approximately HKD 4.7 million by the economic recovery from the lifted of novel coronavirus restrictions since the end of year 2022; and the receipt of government subsidies of approximately HKD 0.8 million in the current year pursuant to the Employment Support Scheme for retention of employment and to combat the COVID-19 pandemic.
Grand Brilliance Group Holdings Limited
Equities
8372
KYG4136R1020
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.094 HKD | -1.05% | -7.84% | -6.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.00% | 9.61M | |
-3.41% | 9.4B | |
+30.20% | 1.92B | |
-3.90% | 1.39B | |
-7.38% | 1.18B | |
-18.42% | 856M | |
+0.48% | 470M | |
+3.62% | 437M | |
-49.68% | 360M | |
-24.72% | 333M |
- Stock Market
- Equities
- 8372 Stock
- News Grand Brilliance Group Holdings Limited
- Grand Brilliance Group Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 March 2023